Monday 31 December 2012

Happy New Year 2013




WISH YOU HAPPY NEW YEAR 2013....

“Another fresh new year is here . . .
Another year to live!
To banish worry, doubt, and fear,
To love and laugh and give!

This bright new year is given me
To live each day with zest . . .
To daily grow and try to be
My highest and my best!

I have the opportunity
Once more to right some wrongs,
To pray for peace, to plant a tree,
And sing more joyful songs!” 


William Arthur Ward

Wednesday 26 December 2012

Drug Patent Expirations for the week of December 23, 2012


Drug Patent Expirations for the week of December 23, 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
ASMANEX TWISTHALERScheringmometasone furoate5,394,868*PEDDec 25, 2012
SPIRIVABoehringer Ingelheimtiotropium bromide monohydrate5,478,578Dec 26, 2012
MAXALT-MLTMerckrizatriptan benzoate5,298,520*PEDDec 29, 2012
MAXALTMerckrizatriptan benzoate5,298,520*PEDDec 29, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Wednesday 19 December 2012

Drug Patent Expirations for the week of December 16, 2012


Drug Patent Expirations for the week of December 16, 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
SYMBICORTAstrazenecabudesonide; formoterol fumarate dihydrate5,972,919Dec 17, 2012
TASMARValeant Pharms Llctolcapone5,476,875Dec 19, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Wednesday 5 December 2012

Drug Patent Expirations for the week of December 2, 2012


Drug Patent Expirations for the week of December 2, 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
NUTROPIN DEPOTGenentechsomatropin recombinant6,051,259Dec 2, 2012
ATACAND HCTAstrazenecacandesartan cilexetil; hydrochlorothiazide5,196,444*PEDDec 4, 2012
ATACANDAstrazenecacandesartan cilexetil5,196,444*PEDDec 4, 2012
PAXIL CRGlaxosmithklineparoxetine hydrochloride5,422,123*PEDDec 6, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Monday 3 December 2012

CCMB Ph.D Programme




Eligibility: B.PharmBE/B.TechMBBSME/M.TechMSc
Location: Hyderabad
Job Category: Others
Last Date: 7 December 12
Job Type: Full Time
Hiring Process: Written-test.
Job Details
Notification No. 6/2012 
Centre for Cellular and Molecular Biology (CCMB), conducts Ph.D Programme Centre for Cellular and Molecular Biology, Hyderabad, invites applications from candidates who are bonafide Indian citizens, to pursue research in modern biology leading to a Ph.D. Degree. The projects offered for Ph.D. would be in the broad areas of Cell Biology, Molecular Biology, Genetics, Genomics, Developmental Biology, Nanobiology, Plant Molecular Biology, Protein Structure & Function, Biology of Macromolecules, Biology of Infection, Epigenetics, Chromatin Biology and Bioinformatics.
Eligibility : Candidates with a Master’s degree in any branch of science having a valid National Level Fellowship (JRF/SRF of various funding agencies, e.g., CSIR, UGC, DBT, ICMR, etc.), DST-INSPIRE or other equivalent fellowship can apply. Candidates with a Bachelor’s degree in Engineering or Pharmacy qualified in GATE/GPAT examination with a minimum of 85 percentile may also apply. Candidates with a Bachelor’s degree in Medicine can also apply. Candidates qualified for lecturer-ship only in CSIR-UGC (NET) examination need not apply.Candidates with a degree in M.Sc or M.Tech qualification with GATE examination need not apply.
Age Limit : 28 years as on 7.12.2012 which is relaxable by 5 years as per GoI rules for SC/ST/OBC/Women/Physically Handicapped candidates. 
Selection Process : The eligible candidates selected for the written test are required to appear for the exam to be held on 22.1.2013 at CCMB, Hyderabad. Candidates qualified in the written test will have to appear for interview on 23.01.2013 and 24.01.2013. Candidates selected in the interview will be asked to stay for discussions on 25.01.2013. Travelling Allowance is not payable by CCMB and candidates have to make their own arrangements for stay, etc., at Hyderabad. Candidates qualified in CSIR-UGC NET Fellowship or ICMR-JRF or DBT-JRF or any other equivalent fellowship can also walk in on the day of the written test (22nd January, 2013) at 7.30 AM into CCMB along with proof of their qualification for the respective fellowship. Mere fulfilment of the minimum requirements stipulated in the notification would not automatically entail a person for selection. The decision of the Centre in this regard shall be final. Canvassing in any form and/or bringing in any influence, political or otherwise, will be treated as a disqualification.

How to apply
Candidates should submit their applications online by 7.12.2012. The Screening Committee will scrutinize the applications and candidates selected for the Written Test will be intimated through email by 15.12.2012.
Important Dates :
Closing Date for online application07.12.2012
Date of written test22.01.2013

Sunday 2 December 2012

BITS Pilani Ph.D. Programmes



BITS Pilani logo
Eligibility: B.PharmM.Pham
Location: Rajasthan-other
Job Category: Scholarships
Last Date: 10 December 12
Job Type: Full Time
Hiring Process: Written-test.

Job Details

Ph.D. Programmes (for 2nd semester 2012-13)

Applications are invited for admission to Ph.D Programme at Pilani, Goa and Hyderabad campuses in the following disciplines : Biological Sciences, Chemical Engg., Chemistry, Civil Engg. Computer Science, Economics and Finance, Electrical & Electronics Engg., Management, Mathematics, Mechanical Engg., Pharmacy, Physics, Languages and Humanities and Interdisciplinary areas such as  Biotechnology, Energy, Environment, Robotics; Nano-science & Nanotechnology, Water Management, Public Health etc. Please visit department  websites for details.
Input Qualification : M.E./M.Pharm./MBA/M.Phil of BITS or its equivalent with a minimum of 60% aggregate. Candidates with an M.Sc./B.E./B.Pharm or an equivalent degree with a minimum of 60% aggregate may also be considered for Ph.D. admission. For Ph.D Programme in Languages and Humanities, candidates with an M.A. and with minimum of 55% aggregate may also be considered. Industries and R&D organizations collaborating with BITS may sponsor candidates to work for Ph.D. under “Aspirants scheme”.
Assistantship/Scholarship : Applicants for admission to the Ph.D. programme will also be considered for Project/Research Assistantships to the tune of Rs. 10,000/- to Rs. 14000/- pm or more in addition to tuition fee waiver of upto 80%. Such selected candidates will be required to participate in teaching and other developmental programme of the institute under the guidance of a mentor.

How to apply
Interested and eligible candidates should apply through the prescribed application form and take the printout of the filled form. The completed application form along with the prescribed fee of Rs. 1600/- should be sent toAdmissions Officer, BITS, Pilani – 333031. Deadline for submission of the completed application form is 5.00 P.M. on 10th December 2012.


OPENING FOR FRESHERS TO WORK AS TERRITORY SALES OFFICER




Eucare Pharmaceuticals Pvt Ltd

Opening for: Territory sales officer


Eligibility: B.Pharm, M.Pharm, BE/B.Tech(Bio-Medical /Bio-Technology Engineering, Chemical Engineering), BSc(Bio-Chemistry, BioInformatics, Biology, Bio-Physics, Bio-technology, Botany / Agricultural Botany, Chemistry / Applied Chemistry, Microbiology, Zoology / Applied Zoology), ME/M.Tech(Bio-Informatics/Bio-Chemistry Engineering, Bio-Medical /Bio-Technology Engineering, Chemical Engineering, Environmental Engineering)

MS, MSc(Bio-Chemistry, BioInformatics, Biology, Bio-Physics, Bio-technology, Botany / Agricultural Botany, Chemistry / Applied Chemistry, Microbiology, Zoology / Applied Zoology)

Freshers will be preferred most.


Location: Anywhere in India


Job Category: Pharma


Last Date: 12 December 12





Friday 30 November 2012

WORLD AIDS DAY, 1st DECEMBER





About World AIDS Day

What is World AIDS Day?

World AIDS Day is held on 1 December each year and is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and to commemorate people who have died. World AIDS Day was the first ever global health day and the first one was held in 1988.

Why is World AIDS Day important?

Around 100,000 are currently living with HIV in the UK and globally an estimated 34 million people have HIV. More than 25 million people between 1981 and 2007 have died from the virus, making it one of the most destructive pandemics in history.
Today, many scientific advances have been made in HIV treatment, there are laws to protect people living with HIV and we understand so much more about the condition. But despite this, people do not know the facts about how to protect themselves and others from HIV, and stigma and discrimination remain a reality for many people living with HIV. World AIDS Day is important as it reminds the public and Government that HIV has not gone away – there is still a vital need to raise money, increase awareness, fight prejudice and improve education.

What should I do on World AIDS Day?

World AIDS Day is an opportunity for you to learn the facts about HIV and put your knowledge into action. Find out how much you know by taking our online quiz: Are you HIV aware? Test your knowledge and awareness by taking the quiz and act aware by passing the quiz on and sharing it with your friends on Twitter and Facebook.

If you understand how HIV is transmitted, how it can be prevented, and the reality of living with HIV today - you can use this knowledge to take care of your own health and the health of others, and ensure you treat everyone living with HIV fairly, and with respect and understanding. Click here to find out the facts.
You can also show your support for people living with HIV on World AIDS Day by wearing a red ribbon, the international symbol of HIV awareness.
World AIDS Day is also a great opportunity to raise money for NAT (National AIDS Trust) and show your support for people living with HIV. If you feel inspired to hold an event, bake sale or simply sell red ribbons,click here to get started. If you'd like to see what other events are taking place — click here and find out more.

But what about after World AIDS Day?

Although World AIDS Day is a great opportunity to get the public talking about HIV and fundraise, we need to remember the importance of raising awareness of HIV all year round. That's why NAT has launched HIVaware— a fun, interactive new website which provides all the information everyone should know about HIV. Why not use what you have learnt on World AIDS Day to Act Aware throughout the year and remember, you can fundraise at any time of year too — NAT is always here to give you suggestions and ideas.

Advances in AIDS treatment



Thirty years ago, the diagnosis of HIV/AIDS was widely seen as a death sentence. In developed countries, thanks to much research and widespread use of anti-viral treatment drugs since 1996, many people with HIV/AIDS can hope for an almost normal lifespan.
In other parts of the world, especially sub-Saharan Africa, HIV/AIDS still decimates populations and creates millions of orphans. According to the international HIV/AIDS charity AVERT, 1.2 million people in sub-Saharan Africa died of AIDS in 2010 and another 1.9 million became infected with HIV.
It is appropriate that the 19th International AIDS Conference convening today in Washington, D.C., chose as its theme "Turning the Tide Together." In a world as inter-related as ours, infectious disease cannot be confined to any village, country or continent. Many approaches must be used to prevent and treat HIV/AIDS, and they must take into consideration vast differences in culture, wealth and education levels.
In the United States, for example, HIV/AIDS was initially noticed as a new and almost universally fatal illness of gay men. Thirty-one years and more than 30 million deaths later, the deadliest infectious disease in the world strikes men both gay and straight, women and children.
But the differences country to country are astounding.
According to the U.S. Centers for Disease Control, three-fourths of the people with an HIV diagnosis in the United States today are men, 74 percent of whom contracted the disease by having sex with other men.
But in sub-Saharan Africa, according to AVERT, 59 percent of the people with an HIV diagnosis are women. Among young people, 70 percent are female. Most were infected through heterosexual transmission.
"In many African countries, sexual relationships are dominated by men, meaning that women cannot always practice safer sex even when they know the risks involved," AVERT states on its website.
There is a belief among some African men that if they have sex with a virgin, it will "cure" their HIV/AIDS. There is often a reluctance to use condoms, or a shortage of them, factors of both cultural practices and poverty. AVERT promotes education as vital to the prevention of HIV/AIDS, something that has been resisted by some African governments until quite recently.
For developed countries, and to some degree the poorer ones, recent announcements will continue to make HIV/AIDS a more preventable, treatable disease. Last week the U.S. Food and Drug Administration approved the first preventive drug for daily use by adults at high risk for sexual acquisition of HIV.
Trade named Truvada, it greatly reduces transmission of HIV between men having sex with other men as well as heterosexual men and women, according to the Centers for Disease Control. The guidelines for using what is called PrEP, short for pre-exposure prophylaxis, will be discussed at the AIDS Conference.
This month, the FDA also approved this month the first rapid home test for HIV diagnosis. The hope is that this will also result in people who test positive beginning treatment sooner.
David Margolis, an HIV researcher at the University of North Carolina at Chapel Hill, spoke about the probability of a cure for HIV/AIDS in an interview with Bloomberg.com earlier this year. "What people want to know is when can someone go to a doctor and be handed a pill and be cured," he said. "That's decades away. I think in 10 years someone with HIV infection could go to a specialist and get a complicated treatment and have some likelihood of a prolonged remission of their HIV."
It's rather like many people with cancer are treated today — no promise of a cure, but a reprieve from a quick death.
Among the many advances in HIV/AIDS since 1981 is the way it is perceived. The World AIDS Conference has not been held in the United States since 1990 because Congress passed a travel ban against HIV-positive people. That ban, a product of the unreasonable fear that characterized much of the first decade of the epidemic, was overturned by Congress in 2008.
In fact, CNN newsman Anderson Cooper, who recently "came out" as a gay man, was featured at a pre-conference party yesterday sponsored by the American Foundation for AIDS Research.
Good for him. Good for our country.